Multi-organs-on-chips for testing small-molecule drugs: challenges and perspectives
dc.authorid | Berivan Çeçen / 0000-0002-0081-2004 | en_US |
dc.authorscopusid | Berivan Çeçen / 24461480700 | en_US |
dc.authorwosid | Berivan Çeçen / Q-4203-2019 | |
dc.contributor.author | Çeçen, Berivan | |
dc.contributor.author | Karavasili, Christina | |
dc.contributor.author | Nazir, Mubashir | |
dc.contributor.author | Bhusal, Anant | |
dc.contributor.author | Doğan, Elvan | |
dc.date.accessioned | 2021-10-28T07:23:39Z | |
dc.date.available | 2021-10-28T07:23:39Z | |
dc.date.issued | 2021 | en_US |
dc.department | İstinye Üniversitesi, Mühendislik ve Doğa Bilimleri Fakültesi, Moleküler Biyoloji ve Genetik Bölümü | en_US |
dc.description.abstract | Organ-on-a-chip technology has been used in testing small-molecule drugs for screening potential therapeutics and regulatory protocols. The technology is expected to boost the development of novel therapies and accelerate the discovery of drug combinations in the coming years. This has led to the development of multi-organ-on-a-chip (MOC) for recapitulating various organs involved in the drug–body interactions. In this review, we discuss the current MOCs used in screening small-molecule drugs and then focus on the dynamic process of drug absorption, distribution, metabolism, and excretion. We also address appropriate materials used for MOCs at low cost and scale-up capacity suitable for high-performance analysis of drugs and commercial high-throughput screening platforms. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. | en_US |
dc.identifier.citation | Berivan Cecen, Christina Karavasili, Mubashir Nazir, Anant Bhusal, Elvan Dogan, Fatemeh Shahriyari, Sedef Tamburaci, Melda Buyukoz, Leyla Didem Kozaci, & Amir K. Miri. (2021). Multi-Organs-on-Chips for Testing Small-Molecule Drugs: Challenges and Perspectives. Pharmaceutics, 13(1657), 1657. https://doi.org/10.3390/pharmaceutics13101657 | en_US |
dc.identifier.doi | 10.3390/pharmaceutics13101657 | en_US |
dc.identifier.endpage | 21 | en_US |
dc.identifier.issn | 1999-4923 | en_US |
dc.identifier.issue | 10 | en_US |
dc.identifier.scopus | 2-s2.0-85117517588 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 1 | en_US |
dc.identifier.uri | https://doi.org/10.3390/pharmaceutics13101657 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/2194 | |
dc.identifier.volume | 13 | en_US |
dc.identifier.wos | WOS:000714080800001 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Çeçen, Berivan | |
dc.language.iso | en | en_US |
dc.publisher | MDPI | en_US |
dc.relation.ispartof | Pharmaceutics | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | High-throughput Screening | en_US |
dc.subject | Microfluidics | en_US |
dc.subject | Multi-organ-on-a-chip | en_US |
dc.subject | Small Drugs | en_US |
dc.title | Multi-organs-on-chips for testing small-molecule drugs: challenges and perspectives | en_US |
dc.type | Article | en_US |